-
1
-
-
33646047427
-
Uterine sarcomas in breast cancer patients treated with tamoxifen
-
Arenas M, Rovirosa A, Hernandez V et al. Uterine sarcomas in breast cancer patients treated with tamoxifen. Int J Gynecol Cancer 2006 16 : 861 865.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 861-865
-
-
Arenas, M.1
Rovirosa, A.2
Hernandez, V.3
-
2
-
-
2542554193
-
Uterine sarcomas: A 10-year experience and a review of the literature
-
Yildirim Y, Inal MM, Sanci M, Sentas A, Hanhan M. Uterine sarcomas: A 10-year experience and a review of the literature. Women's Oncol Rev 2004 4 : 7 12.
-
(2004)
Women's Oncol Rev
, vol.4
, pp. 7-12
-
-
Yildirim, Y.1
Inal, M.M.2
Sanci, M.3
Sentas, A.4
Hanhan, M.5
-
3
-
-
13844304991
-
Tumours of the uterine corpus. Mesenchymal tumours and related lesions
-
In: Tavassoli, F.A., Devilee, P. (. eds). Lyon: IARC Press
-
Hendrickson MR, Tavassoli FA, Kempson RL et al. Tumours of the uterine corpus. Mesenchymal tumours and related lesions. In : Tavassoli FA, Devilee P (eds). World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Breast and Female Genital Organs. Lyon : IARC Press, 2003 233 244.
-
(2003)
World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Breast and Female Genital Organs.
, pp. 233-244
-
-
Hendrickson, M.R.1
Tavassoli, F.A.2
Kempson, R.L.3
-
4
-
-
33750188708
-
Embryonal rhabdomyosarcoma of the uterus. Case report and review of the literature
-
Reynolds EA, Logani S, Moller K, Horowitz IR. Embryonal rhabdomyosarcoma of the uterus. Case report and review of the literature. Gynecol Oncol 2006 103 : 736 739.
-
(2006)
Gynecol Oncol
, vol.103
, pp. 736-739
-
-
Reynolds, E.A.1
Logani, S.2
Moller, K.3
Horowitz, I.R.4
-
5
-
-
0036197799
-
Rhabdomyosarcoma of the uterus: Report of two cases, including one of the spindle cell variant
-
McCluggage WG, Lioe TF, McClelland HR, Lamki H. Rhabdomyosarcoma of the uterus: Report of two cases, including one of the spindle cell variant. Int J Gynecol Cancer 2002 12 : 128 132.
-
(2002)
Int J Gynecol Cancer
, vol.12
, pp. 128-132
-
-
McCluggage, W.G.1
Lioe, T.F.2
McClelland, H.R.3
Lamki, H.4
-
7
-
-
0031214485
-
Pure alveolar rhabdomyosarcoma of the corpus uteri: Description of a case with increased serum level of CA-125
-
Chiarle R, Godio L, Fusi D et al. Pure alveolar rhabdomyosarcoma of the corpus uteri: Description of a case with increased serum level of CA-125. Gynecol Oncol 1997 66 : 320 323.
-
(1997)
Gynecol Oncol
, vol.66
, pp. 320-323
-
-
Chiarle, R.1
Godio, L.2
Fusi, D.3
-
8
-
-
33645050907
-
Uterine rhabdomyosarcoma presenting as acute inversion in an adolescent
-
Sharma A, Rajaram S, Goel N et al. Uterine rhabdomyosarcoma presenting as acute inversion in an adolescent. Aust N Z J Obstet Gynaecol 2006 46 : 58 66.
-
(2006)
Aust N Z J Obstet Gynaecol
, vol.46
, pp. 58-66
-
-
Sharma, A.1
Rajaram, S.2
Goel, N.3
-
9
-
-
30944437587
-
Development of uterine sarcoma after tamoxifen treatment for breast cancer: Report of four cases
-
Yildirim Y, Inal MM, Sanci M et al. Development of uterine sarcoma after tamoxifen treatment for breast cancer: Report of four cases. Int J Gynecol Cancer 2005 15 : 1239 1242.
-
(2005)
Int J Gynecol Cancer
, vol.15
, pp. 1239-1242
-
-
Yildirim, Y.1
Inal, M.M.2
Sanci, M.3
-
10
-
-
0032778145
-
Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy
-
Okada DH, Rowland JB, Petrovic LM. Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy. Gynecol Oncol 1999 75 : 509 513.
-
(1999)
Gynecol Oncol
, vol.75
, pp. 509-513
-
-
Okada, D.H.1
Rowland, J.B.2
Petrovic, L.M.3
-
11
-
-
33746408229
-
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: Long-term safety analysis of the ATAC trial
-
The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group.
-
The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: Long-term safety analysis of the ATAC trial. Lancet Oncol 2006 7 : 633 643.
-
(2006)
Lancet Oncol
, vol.7
, pp. 633-643
-
-
-
12
-
-
0028033883
-
Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years
-
Love RR, Barden HS, Mazess RB et al. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years. Arch Intern Med 1994 154 : 2585 2588.
-
(1994)
Arch Intern Med
, vol.154
, pp. 2585-2588
-
-
Love, R.R.1
Barden, H.S.2
Mazess, R.B.3
-
13
-
-
0345592552
-
Isolation and characterization of a complementary DNA specific for human aromatase-system cytochrome P-450 mRNA
-
Evans CT, Ledesma DB, Schulz TZ et al. Isolation and characterization of a complementary DNA specific for human aromatase-system cytochrome P-450 mRNA. Proc Natl Acad Sci USA 1986 83 : 6387 6391.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 6387-6391
-
-
Evans, C.T.1
Ledesma, D.B.2
Schulz, T.Z.3
-
14
-
-
33745673353
-
Aromatase inhibitors in breast cancer: An overview
-
Atlundag K, Ibrahim NK. Aromatase inhibitors in breast cancer: An overview. Oncologist 2006 11 : 553 562.
-
(2006)
Oncologist
, vol.11
, pp. 553-562
-
-
Atlundag, K.1
Ibrahim, N.K.2
|